Mobic and Asacol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic and Asacol. Common interactions include anaemia among females and foot deformity among males.

The phase IV clinical study analyzes what interactions people who take Mobic and Asacol have. It is created by eHealthMe based on reports of 67 people who take Mobic and Asacol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

67 people who take Mobic and Asacol together, and have interactions are studied.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 25,689 Mobic users for its effectiveness, alternative drugs and more.

What is Asacol?

Asacol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 18,163 Asacol users for its effectiveness, alternative drugs and more.

Number of Mobic and Asacol reports submitted per year:

Common Mobic and Asacol drug interactions by gender *:

female:

Anaemia
Vitreous detachment
Dysphagia
Platelet count increased
Lumbar spinal stenosis
Device failure
Nasal congestion
Scab
Tooth extraction
Bursitis

male:

Foot deformity
Urinary retention
Chest discomfort
Chest pain
Cough
Dyspnoea
Fatigue
Febrile neutropenia
Headache
Influenza

Common Mobic and Asacol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Asthenia
Cellulitis
Cough
Fatigue
Headache
Influenza
Lung infection
Nausea
Oropharyngeal pain
Palmar-plantar erythrodysaesthesia syndrome

30-39:

n/a

40-49:

Fatigue
Renal injury
Renal tubular necrosis
Accident
Anal infection
Asthenia
Blood cholesterol increased
Blood pressure fluctuation
Blood triglycerides increased
Headache

50-59:

Diarrhoea
Enteritis
Enterococcal infection
Escherichia infection
Essential thrombocythaemia
Exostosis
Facial neuralgia
Foot fracture
Gastrooesophageal reflux disease
Generalised oedema

60+:

Abdominal pain
Diarrhoea
Fatigue
Foot deformity
Intervertebral disc protrusion
Nephrolithiasis
Pain in extremity
Pancreatic mass
Psoriatic arthropathy
Rash

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 28 people, 41.79%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 28 people, 41.79%
Thrombocytopenia (decrease of platelets in blood): 11 people, 16.42%
Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 10 people, 14.93%
Pain: 8 people, 11.94%
Stress And Anxiety: 8 people, 11.94%
Insomnia (sleeplessness): 7 people, 10.45%
Depression: 7 people, 10.45%
High Blood Pressure: 6 people, 8.96%
Joint Pain: 5 people, 7.46%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Asacol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .